Stonebrook Private’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Stonebrook Private's REGN Position: Q3 2026 in Review
Stonebrook Private opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 436 shares worth $331K. The stake represents 0.05% of the portfolio and ranks #230 among its holdings. This is a return to the name: Stonebrook Private previously reported a position in REGN as recently as Q4 2025.
Stonebrook Private first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Stonebrook Private held 436 shares of Regeneron Pharmaceuticals worth $331K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Stonebrook Private position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.05% of Stonebrook Private's portfolio in Q3 2026, its #230 holding.
- Stonebrook Private first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Stonebrook Private's 13F filing for Q3 2026, filed 20 Nov 2026.